Trial intelligence / Profile preview

Plenvu vs Picoprep for Colonoscopy Bowel Cleansing

NCT05436054Phase 4Recruiting

Sponsor
Aalborg University Hospital
Start
Oct 2022
Primary completion
Dec 2025
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Phase 4, randomised, single-blind trial of polyethylene glycol + electrolytes + ascorbic acid in Gastrointestinal cleansing (2 arms), sponsored by Aalborg University Hospital. Primary endpoint: Efficacy of cleansing agent at 18 hours. Started Oct 2022; status: recruiting.

02

Drugs

polyethylene glycol + electrolytes + ascorbic acid
03

Conditions

Gastrointestinal cleansing

Beyond the preview

Go deeper on NCT05436054.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05436054.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call